Markers of degeneration and regeneration in Duchenne muscular dystrophy

Acta Myologica

Volumn 28, Issue 3, 2009, Pages 94-100

  Abdel Salam, Ekram ^a   Abdel Meguid, I ^a   Korraa, S S ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL CENTER FOR RADIATION RESEARCH AND TECHNOLOGY   (Egypt)

Author keywords

Apoptosis; Basic fibroblast growth factor; Duchenne muscular dystrophy

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANTIGEN DETECTION; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION PROFILING; HUMAN; LYMPHOCYTE; MALE; MUSCLE ATROPHY; MUSCLE REGENERATION; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CHILD; DNA FRAGMENTATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; PROTO-ONCOGENE PROTEINS C-BCL-2; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77951781389     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Blake D, Weir A, Newey S, Davies K. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 2002;82:291-329. (Pubitemid 34654455)
2. Durbeej M, Campbell K. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev 2002;12:349-361 (Pubitemid 34669835)
3. Emery AEH. The muscular dystrophies. Lancet 2002;359:687-695
4. Tidball J. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 2005;288:R345-53.
5. Zacharias JM, Anderson JE. Muscle regeneration after imposed injury is better in younger than older mdx dystrophic mice. J Neurol Sci 1991;104:190-196
6. Spencer M, Tidball J. Do immune cells promote the pathology of dystrophin-deficient myopathies? Neuromuscul Disord 2001;11:556-564
7. Gorospe J, Tharp M, Hinckley J, et al. A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice. J Neurol Sci 1994;122:44-56. (Pubitemid 24073749)
8. Spencer M, Montecino-Rodriguez E, Dorshkind K, et al. (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle. Clin Immunol 2001;98:235-243 (Pubitemid 32150612)
9. Cai B, Spencer M, Nakamura G, et al. Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors. Am J Pathol 2000;156:1789-1796 (Pubitemid 30646716)
10. Sandri M, Carraro U, Podhorska-Okolov M, et al. Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise. FEBS Lett 1995;373:291-295
11. Sandri M, Minetti C, Pedemonte M, et al. Apoptotic myonuclei in human Duchenne muscular dystrophy. Lab Invest 1998;78:1005-1016 (Pubitemid 28378214)
12. Beauchamp J, Heslop L, Yu D, et al. Expression of CD34 and myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 2000;151:1221-1234
13. Tamaki T, Akatsuka A, Ando K, et al. Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol 2002;157:571-577 (Pubitemid 34839786)
14. Xia J, Xie A, Zhang K, et al. The vascular endothelial growth factor expression and vascular regeneration in infarcted myocardium by skeletal muscle satellite cells. Chin Med J 2006;119:117-121 (Pubitemid 43796927)
15. Germani A, Di Carlo A, Mangoni A, et al. Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol 2003;163:1417-1428 (Pubitemid 37175089)
16. Liu H, Li Q, Liu X, et al. Expression of basic fibroblast growth factor results in the decrease of myostatin mRNA in murine C2C12 myoblasts. Acta Biochim Biophys Sin (Shagahai) 2006;38:697-703. (Pubitemid 44657214)
17. Lefaucheur J, Sebille A. Basic fibroblast growth factor promotes in vivo muscle regeneration in murine muscular dystrophy. Neurosci Lett 1995;29:202:121-124 (Pubitemid 26011570)
18. Collins R, Grounds M. The role of tumour necrosis factor-alpha (TNF-α) in muscle regeneration: studies in TNF-α (-/-) and TNF- α (-/-)/LTα (-/-) mice. J Histochem Cytochem 2001;49:989-1001.
19. Warren G, Hulderman T, Jensen N, et al. Physiological role of tumor necrosis factor alpha in traumatic muscle injury. FASEB J 2002;16:1630-1632
20. Li Y.TNF-α is a mitogen in skeletal muscle. Am J Physiol 2003;285:C370-6.
21. Kuru S, Inukai A, Kato T, et al. Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies. Acta Neuropathol (Berlin) 2003;105:217-24. (Pubitemid 36798812)
22. Torrente Y, El Fahime E, Carson N, et al. Tumor necrosis factor-alpha (TNF-alpha) stimulates chemotactic response in mouse myogenic cells. Cell Transplant 2003;12:91-100. (Pubitemid 36397320)
23. Tews D, Goebel H. DNA-fragmentation and expression of apoptosis-related proteins in muscular dystrophies. Neuropathol Appl Neurobiol 1997;23:331-338 (Pubitemid 27352845)
24. Hengartner M. The biochemistry of apoptosis. Nature 2000;407:770-776
25. Nagata S. Apoptosis by death factor. Cell 1997;88:355-365
26. Brunner T, Mogil R, LaFace D, et al. Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995;373:441-444
27. Kiener P, Davis P, Rankin B, et al. Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J Immunol 1997;159:1594-1598 (Pubitemid 127484141)
28. Laffon B, Pásaro E, Méndez J. Effects of styrene-7,8-oxide over p53, p21, bcl-2 and bax expression in human lymphocyte cultures. Mutagenesis 2001;16:127-132
29. Owen-Schaub LB, Angelo LS, Radinsky R, et al. Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis? Cancer Lett 1995;94:1-8.
30. Ioannou Y, Chen F. Quantification of DNA fragmentation in apoptosis. Nucleic Acid Research 1996;24:992-993
31. El-Ahmady O, El-Salahy E, Mahmoud M, et al. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up. Am J Physiol Heart Circ Physiol 2003;284:H1560-9. (Pubitemid 34857090)
32. Saito K, Kobayashi K, Sasaki M, et al. Detection of human serum tumor necrosis factor- in healthy donors, using a highly sensitive immuno-pcr assay. Clin Chem 1999;45:665-669 (Pubitemid 29220328)
33. Kondoh K, Koyama H, Miyata T, et al. Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor. Cardiovasc Res 2004;61:132-142 (Pubitemid 38056689)
34. Gosselin LE, McCormick KM. Targeting the immune system to improve ventilatory function in muscular dystrophy. Med Sci Sports Exerc 2004;36:44-51.
35. Tews D. Tumour necrosis factor-mediated cell death pathways do not contribute to muscle fibre death in dystrophinopathies. Acta Neuropathol 2005;109:217-225 (Pubitemid 40468392)
36. Dhingra S, Sharma A, Arora R, et al. IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis. Cardiovasc Res 2009;82:59-66.
37. Tews D. and Goebel H. DNA-fragmentation and expression of apoptosis-related proteins in muscular dystrophies. Neuropathol Appl Neurobiol 1997:23:331-338 (Pubitemid 27352845)
38. Behrens L, Bender A, Johnson M, et al. Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells. Brain 1997;120(Pt 6):929-938
39. Oltvai Z, Milliman C, Korsmeyer S. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619 (Pubitemid 23259742)
40. Strasser A, Harris A, Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991;67:889-899 (Pubitemid 121001503)
41. Gupta S. Molecular and biochemical pathways of apoptosis in lymphocytes from aged humans. Vaccine 2000;18:1596-1601 (Pubitemid 30109514)
42. Aggarwal S, Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas Ligand, Bcl-2, and Bax. J Immunol 1998;160:1627-1637 (Pubitemid 28106447)
43. Lim J, Kim D, Bang M. Effects of exercise and steroid on skeletal muscle apoptosis in the mdx mouse. Muscle Nerve 2004;30:456-462 (Pubitemid 39288149)
44. Oxele K, Kohlschutter A. Cause of progression in Duchenne muscular dystrophy: impaired differentiation more probable than replicative aging. Neuropediatrics 2001;32:123-129 (Pubitemid 32747623)
45. Rodriguez M, Trarnopolsky L. Patients with dystrophinopathy show evidence of increased oxidative stress. Free Rad Biol Med 2003;34:1217-1220 (Pubitemid 36423371)
46. Podhorska-Okolow M, Sandri M, Zampieri S, et al. Apoptosis of myofibres and satellite cells: exercise-induced damage in skeletal muscle of the mouse. Neuropathol Appl Neurobiol 1998;24:518-531 (Pubitemid 29002283)
47. Marzetti E, Hwang J, Lees H, et al. Mitochondrial death effectors: Relevance to sarcopenia and disuse muscle atrophy. Biochim Biophys Acta 2009 May 18 [Epub ahead of print].
48. Allen D, Linderman J, Roy R, et al. Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. Am J Physiol 1997;273:C579-C587. (Pubitemid 27396151)
49. Dirks Naylor A, Leeuwenburgh C. Sarcopenia: the role of apoptosis and modulation by caloric restriction. Exerc Sport Sci Rev 2008;36:19-24.
50. Tews D, Goebel H, Meinck H. DNA-fragmentation and apoptosis-related proteins of muscle cells in motor neuron disorders. Acta Neurol Scand 1997;96:380-386 (Pubitemid 28011096)
51. Lim J, Kim D, Bang M. Effects of exercise and steroid on skeletal muscle apoptosis in the mdx mouse. Muscle Nerve 2004;30:456-462 (Pubitemid 39288149)
52. Tidball J, Albrecht D, Lokensgard E, et al. Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci 1995;108:2197-2204
53. Matsuda R, Nishikawa A, Tanaka H. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J Biochem 1995;118:959-964
54. Bonfoco E, Krainc D, Ankarcrona M, et al. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995;92:7162-7166
55. Higuchi M, Honda T, Proske R, et al. Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene 1998;17:2753-2760 (Pubitemid 28554234)
56. Eguchi Y, Shimizu S, Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 1997;57:1835-1840 (Pubitemid 27209706)
57. Baird A, Bohlen P. Fibroblast growth factors. In: Sporn M, Roberts A, eds. Fibroblast growth factors in peptide growth factors and their receptors I. New York: Springer-Verlag 1990, p. 369-418.
58. Anderson J, Liu L, Kardami E. Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerating and regenerating areas of dystrophic (mdx) striated muscles. Dev Biol 1991;147:96-109.
59. D'Amore P, Brown R, Ku P. Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann Neurol 1994;35:362-365 (Pubitemid 24089663)
60. Bansal D, Miyake K, Vogel S. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 2003;423:168-172 (Pubitemid 36569539)
61. Roig M, Roma J, Fargas A. Longitudinal pathologic study of the gastrocnemius muscle group in mdx mice. Acta Neuropathol 2004;107:27-34. (Pubitemid 38088272)
62. Gustafsson T, Puntschart A, Kaijser L et al. Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol Heart Circ Physiol 1999;276:H679-85. (Pubitemid 29100638)
63. Gavin T, Robinson C, Yeager R, et al. Angiogenic growth factor response to acute systemic exercise in human skeletal muscle. J Appl Physiol 2004;96:19-24. (Pubitemid 38031977)
64. Croley A, Zwetsloot K, Westerkamp L, et al. Lower capillarization, VEGF protein, and VEGF mRNA response to acute exercise in the vastus lateralis muscle of aged vs. young women. J Appl Physiol 2005;99:1875-1882 (Pubitemid 41547186)
65. Ryan N, Zwetsloot K, Westerkamp L, et al. Lower skeletal muscle capillarization and VEGF expression in aged vs. young men. J Appl Physiol 2006;100:178-185 (Pubitemid 43671106)
66. Nico B, Corsi P, Vacca A, et al. Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 expression in mdx mouse brain. Brain Res 2002;953:12-16 (Pubitemid 35217802)
67. Nico B, Mangieri D, Crivellato E, et al. HIF activation and VEGF overexpression are coupled with ZO-1 up-phosphorylation in the brain of dystrophic mdx mouse. Brain Pathol 2007;17:399-406. (Pubitemid 47537597)
68. Niebroj-Dobosz I, Fidzianska A, Haumanowa-Petruswicz I. Oxidative damage to muscle proteins in dystrophynopathy. Acta Myologica 2002;XXI:12-17 (Pubitemid 34680118)